Capital Advisors Ltd’s GSK GSK Stock Holding History

Capital Advisors Ltd’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-640	Closed	-$32K	–	461
2018 Q3	$32K	Buy	+640	New	+$32.5K	0.01%	332
2015 Q4	–	Sell	-3,106	Closed	-$149K	–	338
2015 Q3	$149K	Hold	3,106	–	–	0.08%	110
2015 Q2	$162K	Hold	3,106	–	–	0.08%	112
2015 Q1	$179K	Hold	3,106	–	–	0.09%	103
2014 Q4	$166K	Hold	3,106	–	–	0.09%	103
2014 Q3	$178K	Hold	3,106	–	–	0.1%	100
2014 Q2	$208K	Hold	3,106	–	–	0.12%	94
2014 Q1	$207K	Buy	+3,106	New	+$210K	0.12%	91

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Capital Advisors Ltd's GSK Position: Q4 2018 in Review

Capital Advisors Ltd sold out of GSK (GSK) in Q4 2018, closing a stake of 640 shares — an estimated $32K sold.

Capital Advisors Ltd first reported a position in GSK in Q1 2014 and held it in 8 quarters. The position peaked at $208K in Q2 2014. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

Capital Advisors Ltd reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
Capital Advisors Ltd sold 640 GSK shares in Q4 2018, an estimated $32K.
Capital Advisors Ltd first reported a position in GSK in Q1 2014 and held it in 8 quarters.
Capital Advisors Ltd's GSK position peaked at $208K in Q2 2014.
799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Capital Advisors Ltd's 13F filing for Q4 2018, filed 29 Jan 2019.